These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20053487)

  • 1. [Infectious adverse events related to misuse of high-dose buprenorphine: a retrospective study of 42 cases].
    Grau D; Vidal N; Faucherre V; Léglise Y; Pinzani V; Blayac JP; Reynes J; Peyrière H
    Rev Med Interne; 2010 Mar; 31(3):188-93. PubMed ID: 20053487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Infectious complications and misuse of high-dose buprenorphine].
    Cazorla C; Grenier de Cardenal D; Schuhmacher H; Thomas L; Wack A; May T; Rabaud C
    Presse Med; 2005 Jun; 34(10):719-24. PubMed ID: 16026125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
    Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
    Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks.
    De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
    Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B9-15. PubMed ID: 11104938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enterobacter cloacae spondylodiscitis through misuse of high-dose intravenous buprenorphine].
    Etchepare F; Coutaux A; Edel Y; Bourgeois P
    Presse Med; 2005 Jun; 34(10):725-7. PubMed ID: 16026126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychopathology of the misuse of Subutex®: The Popeye syndrome].
    Békaert J; Podevin G
    Encephale; 2015 Jun; 41(3):229-37. PubMed ID: 25212472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine/naloxone induction in heroin-dependent individuals.
    Amass L; Pukeleviciene V; Subata E; Almeida AR; Pieri MC; D'Egidio P; Stankova Z; Costa A; Smyth BP; Sakoman S; Wei Y; Strang J
    Addiction; 2012 Jan; 107(1):142-51. PubMed ID: 21749526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection of buprenorphine and buprenorphine/naloxone tablets in Malaysia.
    Vicknasingam B; Mazlan M; Schottenfeld RS; Chawarski MC
    Drug Alcohol Depend; 2010 Sep; 111(1-2):44-9. PubMed ID: 20478668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous complications among i.v. buprenorphine users.
    Ho RC; Ho EC; Mak A
    J Dermatol; 2009 Jan; 36(1):22-9. PubMed ID: 19207433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heroin detoxification with a single high dose of buprenorphine.
    Kutz I; Reznik V
    Isr J Psychiatry Relat Sci; 2002; 39(2):113-9. PubMed ID: 12227226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid heroin detoxification using a single high dose of buprenorphine.
    Kutz I; Reznik V
    J Psychoactive Drugs; 2001; 33(2):191-3. PubMed ID: 11476266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.
    Andresz V; Marcantoni N; Binder F; Velten M; Alt M; Weber JC; Stephan D
    Addiction; 2006 Sep; 101(9):1347-51. PubMed ID: 16911735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis.
    Peyrière H; Tatem L; Bories C; Pageaux GP; Blayac JP; Larrey D
    Ann Pharmacother; 2009 May; 43(5):973-7. PubMed ID: 19383935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retention and attendance with supervised buprenorphine treatment: a case-note review.
    Bell J; Burrell T
    Drug Alcohol Rev; 2006 Mar; 25(2):161-5. PubMed ID: 16627306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose.
    Clark NC; Lintzeris N; Muhleisen PJ
    Med J Aust; 2002 Feb; 176(4):166-7. PubMed ID: 11913917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of continuing medical education to reduce the risk of buprenorphine diversion.
    Lofwall MR; Wunsch MJ; Nuzzo PA; Walsh SL
    J Subst Abuse Treat; 2011 Oct; 41(3):321-9. PubMed ID: 21664789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose buprenorphine in pregnancy.
    Ross D
    Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):80. PubMed ID: 15089877
    [No Abstract]   [Full Text] [Related]  

  • 18. Infective endocarditis secondary to intravenous Subutex abuse.
    Chong E; Poh KK; Shen L; Yeh IB; Chai P
    Singapore Med J; 2009 Jan; 50(1):34-42. PubMed ID: 19224082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study.
    Daulouède JP; Caer Y; Galland P; Villeger P; Brunelle E; Bachellier J; Piquet JM; Harbonnier J; Leglise Y; Courty P
    J Subst Abuse Treat; 2010 Jan; 38(1):83-9. PubMed ID: 19800758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Necrosis of the glans penis: a complication of an injection of buprenorphin in a opioid abuser].
    Hornez E; Laroche J; Monchal T; Bourgouin S; Riviere P; Fournier R; Dantzer E
    Ann Chir Plast Esthet; 2010 Apr; 55(2):159-61. PubMed ID: 19269730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.